title: Free fatty acids do not acutely increase asymmetrical dimethylarginine concentrations.
abstract: Concentrations of asymmetrical dimethylarginine (ADMA) and free fatty acids (FFAs) are elevated in insulin resistance which is associated with impaired vascular function. We hypothesized that FFAs could alter vascular tone by affecting ADMA concentrations. Plasma FFA levels were increased in seventeen healthy male volunteers by Intralipid/heparin infusion; hemodynamic and biochemical parameters were measured after 90 minutes. Plasma collected before and during Intralipid/heparin or equivalent synthetic FFAs was incubated with human umbilical vein endothelial cells (HUVECs) in vitro. Intralipid/heparin infusion resulted in an approximately seven-fold increase in plasma FFA levels to 1861 +/- 139 micromol/l, which was paralleled by increased systemic blood pressure and forearm blood flow. Intralipid/heparin did not affect ADMA (baseline mean 0.59 [95 % confidence interval [CI]: 0.54; 0.64] and 0.56 [CI: 0.51; 0.59] after 90 minutes), but slightly decreased SDMA (from 0.76, [CI: 0.70; 0.83] to 0.71 [CI: 0.64; 0.74], p < 0.05), and had no effect on ADMA/SDMA ratio. There was no correlation between ADMA and FFA concentrations or forearm blood flow. Incubation of HUVECs with FFA-rich plasma or synthetic FFAs induced an ADMA release after 24 hours, but not after 90 minutes. Acutely increased FFA levels caused hemodynamic effects but did not affect ADMA. Prolonged elevation of FFA levels might influence vascular function by increasing ADMA levels.
authors.affiliation: Department of Clinical Pharmacology, Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, A-1090 Vienna, Austria.
authors.forename: K
authors.initials: K
authors.lastname: Namiranian
authors.forename: F
authors.initials: F
authors.lastname: Mittermayer
authors.forename: M
authors.initials: M
authors.lastname: Artwohl
authors.forename: J
authors.initials: J
authors.lastname: Pleiner
authors.forename: G
authors.initials: G
authors.lastname: Schaller
authors.forename: B X
authors.initials: BX
authors.lastname: Mayer
authors.forename: M
authors.initials: M
authors.lastname: Bayerle-Eder
authors.forename: M
authors.initials: M
authors.lastname: Roden
authors.forename: S
authors.initials: S
authors.lastname: Baumgartner-Parzer
authors.forename: M
authors.initials: M
authors.lastname: Wolzt
mesh_terms: D000328:Adult; D001120:Arginine / Q000031:analogs & derivatives* / Q000097:blood; D001794:Blood Pressure / Q000502:physiology; D042783:Endothelial Cells / Q000378:metabolism*; D004730:Endothelium, Vascular / Q000166:cytology / Q000378:metabolism*; D005217:Fat Emulsions, Intravenous / Q000378:metabolism; D005230:Fatty Acids, Nonesterified / Q000097:blood*; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology*; D008297:Male; D012016:Reference Values; D018709:Statistics, Nonparametric; D014471:Umbilical Veins / Q000166:cytology / Q000378:metabolism
chemical_list: D005217:Fat Emulsions, Intravenous; D005230:Fatty Acids, Nonesterified; C018524:N,N-dimethylarginine; D001120:Arginine